CIK 2032331
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 65.70% | 47 |
| Software & IT Services | 13.43% | 2 |
| Unclassified | 7.29% | 13 |
| Semiconductors & Semiconductor Equipment | 5.78% | 1 |
| Insurance | 3.43% | 3 |
| Health Care Equipment & Supplies | 2.11% | 4 |
| Health Care Providers & Services | 0.88% | 1 |
| Communications Equipment | 0.59% | 1 |
| Life Sciences Tools & Services | 0.55% | 1 |
| Metals & Mining | 0.15% | 1 |
| Equity Real Estate Investment Trusts (REITs) | 0.04% | 1 |
| Electrical Equipment & Components | 0.04% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | GOOGL | Alphabet Inc. | Communication Services | 13.30% |
| 2 | ASX | ASE Technology Holding Co., Ltd. | Information Technology | 5.78% |
| 3 | IONS | IONIS PHARMACEUTICALS INC | Health Care | 4.35% |
| 4 | NBIX | NEUROCRINE BIOSCIENCES INC | Health Care | 4.22% |
| 5 | AXSM | Axsome Therapeutics, Inc. | Health Care | 4.12% |
| 6 | BMRN | BIOMARIN PHARMACEUTICAL INC | Health Care | 4.09% |
| 7 | ASND | Ascendis Pharma A/S | Health Care | 4.02% |
| 8 | PTCT | PTC THERAPEUTICS, INC. | Health Care | 4.02% |
| 9 | PFE | PFIZER INC | Health Care | 2.98% |
| 10 | REGN | REGENERON PHARMACEUTICALS, INC. | Health Care | 2.87% |
63/76 names classified · sector 92.7% of weight · industry 92.7% · mkt cap 79.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 92.7% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 50.0% of book weight (22/76 names) · unclassified 50.0%: ASX, IONS, AXSM, ASND, PRAX, INSM, PTGX, BLTE, EWT, MRNA +44 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | GOOGLALPHABET INC | 31,127 | $9M | 13.3% | ADD 2123% |
| 2 | ASXASE TECHNOLOGY HLDG CO LTD | 179,512 | $4M | 5.8% | NEW |
| 3 | IONSIONIS PHARMACEUTICALS INC | 38,988 | $3M | 4.4% | ADD 56% |
| 4 | NBIXNEUROCRINE BIOSCIENCES INC | 21,556 | $3M | 4.2% | ADD 513% |
| 5 | AXSMAXSOME THERAPEUTICS INC. | 16,401 | $3M | 4.1% | ADD 677% |
| 6 | BMRNBIOMARIN PHARMACEUTICAL INC | 48,719 | $3M | 4.1% | NEW |
| 7 | ASNDASCENDIS PHARMA A/S | 11,828 | $3M | 4.0% | ADD 295% |
| 8 | PTCTPTC THERAPEUTICS INC | 39,701 | $3M | 4.0% | ADD 330% |
| 9 | PFEPFIZER INC | 71,313 | $2M | 3.0% | ADD 65% |
| 10 | REGNREGENERON PHARMACEUTICALS | 2,502 | $2M | 2.9% | ADD 63% |
| 11 | JNJJOHNSON & JOHNSON | 7,902 | $2M | 2.9% | TRIM −97% |
| 12 | AMGNAMGEN INC | 4,934 | $2M | 2.6% | TRIM −17% |
| 13 | GILDGILEAD SCIENCES INC | 11,961 | $2M | 2.5% | TRIM −38% |
| 14 | VRTXVERTEX PHARMACEUTICALS INC | 3,412 | $2M | 2.3% | HOLD |
| 15 | UNHUNITEDHEALTH GROUP INC | 5,216 | $1M | 2.1% | NEW |
| 16 | PRAXPRAXIS PRECISION MEDICINES I | 3,855 | $1M | 1.8% | ADD 85% |
| 17 | INSMINSMED INC | 7,018 | $1M | 1.7% | TRIM −39% |
| 18 | PTGXPROTAGONIST THERAPEUTICS INC | 9,334 | $983,804 | 1.5% | NEW |
| 19 | BLTEBELITE BIO INC | 6,004 | $957,278 | 1.4% | ADD 97% |
| 20 | EWTISHARES INC MSCI TAIWAN ETF | 12,500 | $886,500 | 1.3% | NEW |
| 21 | MRNAMODERNA INC | 17,097 | $868,528 | 1.3% | NEW |
| 22 | BIIBBIOGEN INC | 4,706 | $862,751 | 1.3% | ADD 65% |
| 23 | TEVATEVA PHARMACEUTICAL INDS LTD | 25,805 | $777,247 | 1.2% | TRIM −83% |
| 24 | RVMDREVOLUTION MEDICINES INC | 7,971 | $775,180 | 1.2% | ADD 149% |
| 25 | XLUSELECT SECTOR SPDR TR | 16,400 | $752,596 | 1.1% | TRIM −68% |
| 26 | OSGOCTAVE SPECIALTY GROUP INC | 139,168 | $647,131 | 1.0% | TRIM −31% |
| 27 | TWSTTWIST BIOSCIENCE CORP | 13,476 | $640,380 | 1.0% | ADD 35% |
| 28 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,192 | $623,976 | 0.9% | ADD 221% |
| 29 | TLTISHARES TR | 7,100 | $615,499 | 0.9% | NEW |
| 30 | BNTXBIONTECH SE | 6,890 | $612,383 | 0.9% | NEW |
| 31 | NTRANATERA INC | 2,970 | $593,970 | 0.9% | NEW |
| 32 | AXGNAXOGEN INC | 16,273 | $539,124 | 0.8% | TRIM −15% |
| 33 | XLISELECT SECTOR SPDR TR | 3,300 | $533,709 | 0.8% | ADD 18% |
| 34 | COGTCOGENT BIOSCIENCES INC | 13,784 | $530,546 | 0.8% | ADD 87% |
| 35 | XLESELECT SECTOR SPDR TR | 8,500 | $520,710 | 0.8% | ADD 372% |
| 36 | XLPSELECT SECTOR SPDR TR | 6,300 | $516,474 | 0.8% | NEW |
| 37 | CYTKCYTOKINETICS INC | 7,388 | $486,943 | 0.7% | ADD 65% |
| 38 | GMABGENMAB A/S | 16,030 | $430,085 | 0.6% | TRIM −63% |
| 39 | BBIOBRIDGEBIO PHARMA INC | 5,785 | $429,594 | 0.6% | ADD 98% |
| 40 | TNGXTANGO THERAPEUTICS INC | 20,463 | $428,086 | 0.6% | NEW |
| 41 | COOCOOPER COS INC | 5,896 | $421,564 | 0.6% | TRIM −43% |
| 42 | LLYELI LILLY & CO | 442 | $406,538 | 0.6% | TRIM −95% |
| 43 | ERASERASCA INC | 24,847 | $402,024 | 0.6% | NEW |
| 44 | LITELUMENTUM HLDGS INC | 562 | $394,951 | 0.6% | TRIM −95% |
| 45 | ILMNILLUMINA INC | 3,026 | $372,985 | 0.6% | NEW |
| 46 | BIOABIOAGE LABS INC | 20,796 | $363,722 | 0.5% | NEW |
| 47 | APGEAPOGEE THERAPEUTICS INC | 4,007 | $337,269 | 0.5% | TRIM −37% |
| 48 | IBRXIMMUNITYBIO INC | 41,005 | $314,508 | 0.5% | NEW |
| 49 | UTHRUnited Therapeutics Corp. | 527 | $312,500 | 0.5% | NEW |
| 50 | DYNDYNE THERAPEUTICS INC | 17,213 | $312,072 | 0.5% | ADD 20% |
| 51 | SYRESPYRE THERAPEUTICS INC | 6,140 | $309,702 | 0.5% | TRIM −55% |
| 52 | TYRATYRA BIOSCIENCES INC | 8,075 | $309,273 | 0.5% | NEW |
| 53 | XLFSELECT SECTOR SPDR TR | 6,200 | $306,094 | 0.5% | TRIM −74% |
| 54 | SPYSTATE STR SPDR S&P 500 ETF T | 420 | $273,143 | 0.4% | NEW |
| 55 | ALMSALUMIS INC | 12,031 | $265,043 | 0.4% | NEW |
| 56 | ORKAORUKA THERAPEUTICS INC | 5,147 | $252,460 | 0.4% | NEW |
| 57 | EQHEQUITABLE HLDGS INC | 6,794 | $252,125 | 0.4% | NEW |
| 58 | FLTWFRANKLIN TEMPLETON ETF TR FTSE TAIWAN | 3,700 | $252,007 | 0.4% | NEW |
| 59 | SMMTSUMMIT THERAPEUTICS INC | 12,136 | $230,099 | 0.3% | NEW |
| 60 | NVSTENVISTA HOLDINGS CORPORATION | 9,001 | $228,355 | 0.3% | TRIM −39% |
| 61 | CGONCG ONCOLOGY INC | 3,370 | $228,082 | 0.3% | NEW |
| 62 | DXCMDEXCOM | 3,628 | $227,838 | 0.3% | NEW |
| 63 | NKTRNEKTAR THERAPEUTICS | 2,830 | $203,619 | 0.3% | TRIM −43% |
| 64 | GPCRSTRUCTURE THERAPEUTICS INC | 4,190 | $201,958 | 0.3% | NEW |
| 65 | VSTMVERASTEM INC | 36,170 | $191,701 | 0.3% | NEW |
| 66 | GDXVANECK ETF TRUST GOLD MINERS ETF | 2,000 | $183,540 | 0.3% | TRIM −68% |
| 67 | CLYMCLIMB BIO INC | 24,590 | $168,442 | 0.3% | NEW |
| 68 | UAMYUNITED STATES ANTIMONY CORP | 11,426 | $99,749 | 0.1% | NEW |
| 69 | GOOGALPHABET INC | 300 | $86,058 | 0.1% | ADD 50% |
| 70 | IOVAIOVANCE BIOTHERAPEUTICS INC | 19,760 | $69,358 | 0.1% | NEW |
| 71 | NMRANEUMORA THERAPEUTICS INC. | 16,000 | $31,200 | 0.0% | NEW |
| 72 | BDNBRANDYWINE RLTY TR | 10,700 | $28,997 | 0.0% | NEW |
| 73 | XLKSELECT SECTOR SPDR TR | 200 | $26,580 | 0.0% | TRIM −98% |
| 74 | PLUGPLUG PWR INC | 11,208 | $25,330 | 0.0% | NEW |
| 75 | INDAISHARES TR | 500 | $23,420 | 0.0% | HOLD |
| 76 | KWEBKRANESHARES TRUST CSI CHI INTERNET | 400 | $11,372 | 0.0% | TRIM −99% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| GOOGLALPHABET INC | — | — | — | — | 1K | 31K | $9M |
| ASXASE TECHNOLOGY HLDG CO LTD | 39K | — | — | — | — | 180K | $4M |
| IONSIONIS PHARMACEUTICALS INC | — | — | — | 5K | 25K | 39K | $3M |
| NBIXNEUROCRINE BIOSCIENCES INC | — | — | — | — | 4K | 22K | $3M |
| AXSMAXSOME THERAPEUTICS INC. | — | — | — | — | 2K | 16K | $3M |
| BMRNBIOMARIN PHARMACEUTICAL INC | — | — | — | — | — | 49K | $3M |
| ASNDASCENDIS PHARMA A/S | — | — | — | — | 3K | 12K | $3M |
| PTCTPTC THERAPEUTICS INC | — | — | — | 3K | 9K | 40K | $3M |
| PFEPFIZER INC | — | — | — | — | 43K | 71K | $2M |
| REGNREGENERON PHARMACEUTICALS | — | 950 | — | — | 2K | 3K | $2M |
| JNJJOHNSON & JOHNSON | — | — | — | — | 314K | 8K | $2M |
| AMGNAMGEN INC | 5K | — | — | 100 | 6K | 5K | $2M |
| GILDGILEAD SCIENCES INC | — | — | — | — | 19K | 12K | $2M |
| VRTXVERTEX PHARMACEUTICALS INC | — | 457 | — | — | 3K | 3K | $2M |
| UNHUNITEDHEALTH GROUP INC | — | 1K | — | — | — | 5K | $1M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
